Cargando…

In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011

SR9009 and SR9011 are attractive as performance-enhancing substances due to their REV-ERB agonist effects and thus circadian rhythm modulation activity. Although no pharmaceutical preparations are available yet, illicit use of SR9009 and SR9011 for doping purposes can be anticipated, especially sinc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geldof, Lore, Deventer, Koen, Roels, Kris, Tudela, Eva, Van Eenoo, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085709/ https://www.ncbi.nlm.nih.gov/pubmed/27706103 http://dx.doi.org/10.3390/ijms17101676

Ejemplares similares

The Effect of Rev-erbα Agonist SR9011 on the Immune Response and Cell Metabolism of Microglia
por: Wolff, Samantha E. C., et al.
Publicado: (2020)

REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022)

Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells
por: Wagner, Paula M., et al.
Publicado: (2019)

SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022)

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway
por: Sheng, Mingyue, et al.
Publicado: (2023)

SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy
por: Shen, Weitao, et al.
Publicado: (2020)

The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
por: Ishimaru, Kayoko, et al.
Publicado: (2019)

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022)

Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis
por: Wang, Rui, et al.
Publicado: (2023)

SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis
por: Hu, Ming, et al.
Publicado: (2022)

Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
por: Gao, Li‐Bin, et al.
Publicado: (2021)

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists
por: Solt, Laura A., et al.
Publicado: (2012)

Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)

SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
por: Reitz, Cristine J., et al.
Publicado: (2019)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
por: Murray, Meghan H., et al.
Publicado: (2022)

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

Rev-erb Agonist Inhibits Chikungunya and O’nyong’nyong Virus Replication
por: Hwang, Jesse, et al.
Publicado: (2018)

REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
por: Ikeda, Ryosuke, et al.
Publicado: (2019)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle
por: Amador, Ariadna, et al.
Publicado: (2018)

Rev-erbα Inhibits Proliferation and Promotes Apoptosis of Preadipocytes through the Agonist GSK4112
por: Chu, Guiyan, et al.
Publicado: (2019)

Myocardial Rev-erb–Mediated Diurnal Metabolic Rhythm and Obesity Paradox
por: Song, Shiyang, et al.
Publicado: (2022)

Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis
por: Raza, Ghulam Shere, et al.
Publicado: (2022)

Direct Regulation of CLOCK Expression by REV-ERB
por: Crumbley, Christine, et al.
Publicado: (2011)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

REV-ERB is essential in cardiac fibroblasts homeostasis
por: Luo, Xiaokang, et al.
Publicado: (2022)

The Role of REV-ERB Receptors in Cancer Pathogenesis
por: Gomatou, Georgia, et al.
Publicado: (2023)

Evaluation and identification of stem rust resistance genes Sr2, Sr24, Sr25, Sr26, Sr31 and Sr38 in wheat lines from Gansu Province in China
por: Xu, Xiao Feng, et al.
Publicado: (2017)

Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBα
por: Hering, Yuliya, et al.
Publicado: (2018)

REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice
por: Shao, Ruyue, et al.
Publicado: (2021)

The wheat Sr22, Sr33, Sr35 and Sr45 genes confer resistance against stem rust in barley
por: Hatta, M. Asyraf Md, et al.
Publicado: (2020)

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation
por: Amador, Ariadna, et al.
Publicado: (2016)

Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration
por: Meier, Volker, et al.
Publicado: (2006)

Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism
por: Stujanna, Endin Nokik, et al.
Publicado: (2017)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

In vitro and in vivo degradation behavior of Mg–2Sr–Ca and Mg–2Sr–Zn alloys
por: Chen, Kai, et al.
Publicado: (2020)

Transportin-SR, a Nuclear Import Receptor for SR Proteins
por: Kataoka, Naoyuki, et al.
Publicado: (1999)

Identical transitions in the strongly deformed Sr-99 and Sr-100
por: Lhersonneau, G., et al.
Publicado: (2001)

(2SR,4aSR,8aSR)-6-Oxoperhydronaphthalene-2-carboxylic acid
por: Efthimiopoulos, Georgia, et al.
Publicado: (2008)

Electronic properties and surface reactivity of SrO-terminated SrTiO(3) and SrO-terminated iron-doped SrTiO(3)
por: Staykov, Aleksandar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kdgsdqe9bf5h39bpqp1js79grj